Market Report, "DiaGenic ASA (DIAG) - Product Pipeline Analysis, 2013 Update", Published
DiaGenic ASA (DiaGenic) is a life sciences company. The company operates through one segment, which is research, development, sales and marketing of blood based gene expression tests. It develops blood based biomarkers for premature detection of Alzheimer's disease. DiaGenic develops products for unmet needs related to Alzheimer's diagnosis and treatment. The company makes vitro diagnostic (IVD) products and is emphasizing IVD biomarker products in the field of Alzheimer's disease (AD). DiaGenic plans to develop this product, MCItect, awaiting FDA clearance....
View full press release